Works matching IS 17762596 AND DT 2012 AND VI 7 AND IP 4

Results: 10

Hyperbaric oxygen therapy and cancer--a review.

Published in:

2012

By:

Moen I;
Stuhr LE;
Moen, Ingrid;
Stuhr, Linda E B

Publication type:

journal article

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

Published in:

2012

By:

Sartore-Bianchi, Andrea;
Bencardino, Katia;
Nicolantonio, Federica;
Pozzi, Federico;
Funaioli, Chiara;
Gambi, Valentina;
Arena, Sabrina;
Martini, Miriam;
Lamba, Simona;
Cassingena, Andrea;
Schiavo, Roberta;
Bardelli, Alberto;
Siena, Salvatore

Publication type:

Correction Notice

Biosimilars and market access: a question of comparability and costs?

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 227, doi. 10.1007/s11523-011-0192-7

By:

Simoens, Steven;
Verbeken, Gilbert;
Huys, Isabelle

Publication type:

Article

Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 243, doi. 10.1007/s11523-012-0221-1

By:

Saponara, Maristella;
Pantaleo, Maria;
Nannini, Margherita;
Biasco, Guido

Publication type:

Article

Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 213, doi. 10.1007/s11523-012-0223-z

By:

Imano, Motohiro;
Satou, Takao;
Itoh, Tatsuki;
Yasuda, Atsushi;
Kato, Hiroaki;
Shinkai, Masayuki;
Peng, Ying-Feng;
Tsubaki, Masahiro;
Yasuda, Takushi;
Imamoto, Haruhiko;
Nishida, Shozo;
Takeyama, Yoshifumi;
Okuno, Kiyokata;
Shiozaki, Hitoshi

Publication type:

Article

Hyperbaric oxygen therapy and cancer-a review.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 233, doi. 10.1007/s11523-012-0233-x

By:

Moen, Ingrid;
Stuhr, Linda

Publication type:

Article

Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 247, doi. 10.1007/s11523-012-0235-8

By:

Neuhaus, Thomas;
Luyken, Joachim

Publication type:

Article

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 253, doi. 10.1007/s11523-012-0237-6

By:

Le Tourneau, Christophe;
Kamal, Maud;
Trédan, Olivier;
Delord, Jean-Pierre;
Campone, Mario;
Goncalves, Anthony;
Isambert, Nicolas;
Conroy, Thierry;
Gentien, David;
Vincent-Salomon, Anne;
Pouliquen, Anne-Lise;
Servant, Nicolas;
Stern, Marc-Henri;
Le Corroller, Anne-Gaëlle;
Armanet, Sébastien;
Rio Frio, Thomas;
Paoletti, Xavier

Publication type:

Article

Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 217, doi. 10.1007/s11523-012-0236-7

By:

Dai, Furong;
Zhang, Yi;
Zhu, Xin;
Shan, Nianchun;
Chen, Yuxiang

Publication type:

Article

Oncology in 2012: from personalized medicine to precision medicine.

Published in:

2012

By:

Morere, J.

Publication type:

Editorial